N. Hernandez-Pedro - Lab Med Personalizada, Inst Nacl Cancerol SSA

L.A. Cabrera, A. Aviles-Salas,N. Hernandez-Pedro, M. Orozco-Morales, D. Motola-Kuba, W. Muñoz, M. Ramos-Ramirez,D. Heredia,L. Lara-Mejia, P.D. Soberanis-Piña, L. Corrales, C. Martin,

Journal of Thoracic Oncologyno. 9 (2022)

引用0浏览0引用

KRAS Alterations, Clinicopathological Features and Co-occurring Drivers Associated with Prognosis in Advanced NSCLC Patients

M. Ramos-Ramirez,N. Hernandez-Pedro, P. D. Soberanis-Pina, L. A. Cabrera, E. Conde-Flores,D. Heredia, M. Morales-Garcia,D. Diaz-Garcia, A. Valencia-Velarde,L. Lara-Mejia, G. Cruz-Rico,O. Arrieta

Journal of Thoracic Oncologyno. 9 (2022): S598-S598

引用1浏览0引用

Prevalence of the synonymous EGFR Q787Q variant in Mexican patients with non-small cell lung cancer

M. Ramos-Ramirez,N. Y. Hernandez-Pedro, M. Arroyo-Hernandez, A. Aviles-Salas, L. A. Cabrera Miranda, K. Martinez-Perez, S. Monraz-Perez, O. G. Arrieta Rodriguez

Annals of Oncologyno. 7 (2022): S1068-S1068

引用0浏览0引用

Integrating PD-L1 Expression to the CALGB Prognostic Scoring System in Malignant Pleural Mesothelioma

L. A. Cabrera, A. Aviles-Salas,N. Hernandez-Pedro, M. Orozco-Morales, D. Motola-Kuba, W. Munoz, M. Ramos-Ramirez,D. Heredia,L. Lara-Mejia, P. D. Soberanis-Pina,L. Corrales,C. Martin,

JOURNAL OF THORACIC ONCOLOGY（2022）

引用0浏览0引用

P45.11 Co-occurring CDKN2A/B Alteration Is Associated With Worse Survival Outcomes in Advanced ALK-Positive Non-Small Cell Lung Cancer

L. Lara-Mejía, D. Heredia,N. Hernández-Pedro, E. Varela-Santoyo, G. Cruz-Rico, A. Cardona Zorrilla, L. Cabrera Miranda,M. Ramos, F. Barrón,O. Arrieta

Journal of Thoracic Oncologyno. 10 (2021): S1090

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn